Trial intelligence / Profile preview

Allopurinol Augmentation for Treatment Resistant Mania

NCT00643123Phase 4Completed

Sponsor
Cedars-Sinai Medical Center
Start
Sep 2007
Primary completion
Jun 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of allopurinol in bipolar disorder (BD), sponsored by Cedars-Sinai Medical Center. Started Sep 2007; status: completed.

02

Drugs

allopurinol
03

Conditions

bipolar disorder (BD)

Beyond the preview

Go deeper on NCT00643123.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00643123.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call